Moreno N - Search Results

1

Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors.

Graf M, Interlandi M, Moreno N, Holdhof D, Göbel C, Melcher V, Mertins J, Albert TK, Kastrati D, Alfert A, Holsten T, de Faria F, Meisterernst M, Rossig C, Warmuth-Metz M, Nowak J, Meyer Zu Hörste G, Mayère C, Nef S, Johann P, Frühwald MC, Dugas M, Schüller U, Kerl K. Graf M, et al. Among authors: moreno n. Nat Commun. 2022 Mar 22;13(1):1544. doi: 10.1038/s41467-022-29152-4. Nat Commun. 2022. PMID: 35318328 Free PMC article.

2

The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.

Kerl K, Ries D, Unland R, Borchert C, Moreno N, Hasselblatt M, Jürgens H, Kool M, Görlich D, Eveslage M, Jung M, Meisterernst M, Frühwald M. Kerl K, et al. Among authors: moreno n. BMC Cancer. 2013 Jun 13;13:286. doi: 10.1186/1471-2407-13-286. BMC Cancer. 2013. PMID: 23764045 Free PMC article.

3

Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.

Kerl K, Moreno N, Holsten T, Ahlfeld J, Mertins J, Hotfilder M, Kool M, Bartelheim K, Schleicher S, Handgretinger R, Schüller U, Meisterernst M, Frühwald MC. Kerl K, et al. Among authors: moreno n. Int J Cancer. 2014 Aug 15;135(4):989-95. doi: 10.1002/ijc.28719. Epub 2014 Jan 25. Int J Cancer. 2014. PMID: 24420698

4

Loss of Smarc proteins impairs cerebellar development.

Moreno N, Schmidt C, Ahlfeld J, Pöschl J, Dittmar S, Pfister SM, Kool M, Kerl K, Schüller U. Moreno N, et al. J Neurosci. 2014 Oct 1;34(40):13486-91. doi: 10.1523/JNEUROSCI.2560-14.2014. J Neurosci. 2014. PMID: 25274825 Free PMC article.

5

Preclinical Evaluation of Combined Targeted Approaches in Malignant Rhabdoid Tumors.

Moreno N, Kerl K. Moreno N, et al. Anticancer Res. 2016 Aug;36(8):3883-7. Anticancer Res. 2016. PMID: 27466490

6

BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.

Krämer KF, Moreno N, Frühwald MC, Kerl K. Krämer KF, et al. Among authors: moreno n. Int J Mol Sci. 2017 Jul 16;18(7):1537. doi: 10.3390/ijms18071537. Int J Mol Sci. 2017. PMID: 28714904 Free PMC article.

7

Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors.

Moreno N, Holsten T, Mertins J, Zhogbi A, Johann P, Kool M, Meisterernst M, Kerl K. Moreno N, et al. Oncotarget. 2017 Jun 21;8(49):84986-84995. doi: 10.18632/oncotarget.18583. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156698 Free PMC article.

8

The BAF complex in development and disease.

Alfert A, Moreno N, Kerl K. Alfert A, et al. Among authors: moreno n. Epigenetics Chromatin. 2019 Mar 21;12(1):19. doi: 10.1186/s13072-019-0264-y. Epigenetics Chromatin. 2019. PMID: 30898143 Free PMC article. Review.

9

Zeolitic Imidazolate Framework-8 as pH-Sensitive Nanocarrier for "Arsenic Trioxide" Drug Delivery.

Ettlinger R, Moreno N, Volkmer D, Kerl K, Bunzen H. Ettlinger R, et al. Among authors: moreno n. Chemistry. 2019 Oct 11;25(57):13189-13196. doi: 10.1002/chem.201902599. Epub 2019 Sep 13. Chemistry. 2019. PMID: 31336004 Free PMC article.

10

Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance.

Melcher V, Graf M, Interlandi M, Moreno N, de Faria FW, Kim SN, Kastrati D, Korbanka S, Alfert A, Gerß J, Meyer Zu Hörste G, Hartmann W, Frühwald MC, Dugas M, Schüller U, Hasselblatt M, Albert TK, Kerl K. Melcher V, et al. Among authors: moreno n. Acta Neuropathol. 2020 May;139(5):913-936. doi: 10.1007/s00401-019-02116-7. Epub 2019 Dec 17. Acta Neuropathol. 2020. PMID: 31848709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters